The possible mediating mechanisms of insulin action come from studies showing a binding relationship between T2DM and the development of AD and showing that AD patients have a reduction in insulin signaling in the hippocampus along with brain hypometabolism and beta-amyloid (Aβ) accumulation [71,125,126,127,128]. The gene discussed is INS; the disease is Alzheimer disease.